Showing 1 - 16 results of 16 for search 'S F Sokolov', query time: 0.05s
Refine Results
-
1
-
2
-
3
THE METHODOLOGICAL ASPECTS OF FORMATION AND DEVELOPMENT OF E-GOVERNMENT OF THE REGION by A.E. Kalinina, E.A. Petrova, A.F. Sokolov
Published 2008-12-01
Article -
4
EFFECT OF SPIRAPRIL ON THE LENGTH OF INTERICTAL INTERVAL IN PAROXYSMAL ATRIAL FIBRILLATION by L. N. Chikhireva, V. I. Malahov, E. S. Bykova, S. F. Sokolov
Published 2015-12-01
Article -
5
EFFECT OF SPIRAPRIL ON THE LENGTH OF INTERICTAL INTERVAL IN PAROXYSMAL ATRIAL FIBRILLATION by L. N. Chikhireva, V. I. Malahov, E. S. Bykova, S. F. Sokolov
Published 2015-12-01
Article -
6
-
7
-
8
Safety and Effectiveness of Electrical and Pharmacological Cardioversion in Persistent Atrial Fibrillation. Part I: Study Rationale, Design and Assessment of Effectiveness by N. Yu. Mironov, V. V. Vlodzyanovskiy, Yu. A. Yuricheva, S. F. Sokolov, S. P. Golitsyn, L. V. Rosenstraukh, E. I. Chazov
Published 2018-11-01
Article -
9
-
10
-
11
Safety and Effectiveness of Electrical and Pharmacological Cardioversion in Persistent Atrial Fibrillation. Part 2: Assessment of Safety by N. Yu. Mironov, V. V. Vlodzyanovskiy, Yu. A. Yuricheva, S. F. Sokolov, S. P. Golitsyn, L. V. Rosenstraukh, E. I. Chazov
Published 2019-01-01
Article -
12
Intravenous Cavutilide for Pharmacological Conversion of Paroxysmal and Persistent Atrial Fibrillation in Patients with Heart Failure by Maria M. Beliaeva, Khava M. Dzaurova, Yulia A. Yuricheva, Peter S. Novikov, Nikolay Yu. Mironov, Gennady S. Tarasovskiy, Maksim A. Zelberg, Sergey F. Sokolov, Sergey P. Golitsyn
Published 2023-12-01
Article -
13
Changes of NT-proBNP and sST2 levels for predicting isolated episodes of ventricular tachyarrhythmias and electrical storm in patients with systolic heart failure and various impla... by A. Zh. Gasparyan, E. V. Guseva, G. S. Tarasovsky, S. Yu. Kashtanova, M. D. Utsumueva, T. V. Sharf, N. A. Mironova, S. F. Sokolov, V. P. Masenko, A. A. Skvortsov, N. B. Shlevkov
Published 2020-12-01
Article -
14
Efficiency and safety of using the modified protocol for the administration of the domestic class III antiarrhythmic drug for the relief of paroxysmal atrial fibrillation by Khava M. Dzaurova, Nikolay Yu. Mironov, Yuliia A. Yuricheva, Vladislav V. Vlodzyanovsky, Nataliia A. Mironova, Lada Yu. Laiovich, Tatiana A. Malkina, Liudmila V. Zinchenko, Sergei F. Sokolov, Sergey P. Golitsyn
Published 2021-09-01
Article -
15
Safety and Effectiveness of Pharmacologic Conversion of Atrial Fibrillation and Flutter: Results of Multicenter Trial. Part I: Study Rationale, Design and Assessment of Effectivene... by N. Yu. Mironov, Yu. A. Yuricheva, V. V. Vlodzyanovskiy, S. F. Sokolov, Kh. M. Dzaurova, S. P. Golitsyn, Yu. V. Shubik, M. V. Berman, M. M. Medvedev, A. E. Rivin, D. S. Parkhomchuk, A. E. Barybin, D. А. Balandin, R. E. Batalov, D. S. Terekhov, I. V. Evstifeev, I. R. Kildeev, O. V. Pyataeva, S. A. Zenin
Published 2021-05-01
Article -
16
Safety and Effectiveness of Pharmacologic Conversion of Atrial Fibrillation and Flutter: Results of Multicenter Trial. Part II: Assessment of Safety by N. Yu. Mironov, Yu. A. Yuricheva, V. V. Vlodzyanovskiy, S. F. Sokolov, Kh. M. Dzaurova, S. P. Golitsyn, Yu. V. Shubik, M. V. Berman, M. M. Medvedev, A. E. Rivin, D. S. Parkhomchuk, A. E. Barybin, D. А. Balandin, R. E. Batalov, D. V. Terekhov, I. V. Evstifeev, I. R. Kildeev, O. V. Pyataeva, S. A. Zenin
Published 2021-11-01
Article